BetterLife Pharma (BETRF) Beginning Cash Balance (2019 - 2026)

BetterLife Pharma's Beginning Cash Balance history runs 8 years deep, the most recent figure standing at $9169.9 for Q2 2026.

• In Q2 2026, Beginning Cash Balance rose 59.52% year-over-year to $9169.9; the TTM figure through Apr 2026 stood at $14918.2 (down 55.23% YoY), while the FY2023 annual figure was $132777.2, up 7.48% from the prior year.
• Beginning Cash Balance for Q2 2026 stood at $9169.9, up from $5748.3 in the prior quarter.
• The five-year high for Beginning Cash Balance was $136998.1 in Q2 2022, with the low at $5748.3 in Q2 2025.
• The 5-year median for Beginning Cash Balance is $9169.9 (2026), against an average of $37125.4.
• The sharpest annual moves came in 2023 and 2024: Beginning Cash Balance tumbled 95.52% in 2023, then soared 349.1% in 2024.
• BetterLife Pharma's Beginning Cash Balance stood at $136998.1 in 2022, then tumbled by 95.52% to $6139.3 in 2023, then jumped by 349.1% to $27571.5 in 2024, then tumbled by 79.15% to $5748.3 in 2025, then jumped by 59.52% to $9169.9 in 2026.
• Business Quant data shows BETRF's Beginning Cash Balance at $9169.9 in Q2 2026, $5748.3 in Q2 2025, and $27571.5 in Q2 2024.